Searched for
EPILEPSY TREATMENT RESEARCH
Scientists develop a new way to test autism & epilepsy treatments: Why traditional mice cannot explain complex human brain disordersScientists have implanted human brain organoids into specially engineered mice. These human cells survived and connected with the animals' ...- At just 13, Andy Barrett turned a school 3D printer into a small business, selling 150 fidget toys while using his earnings to support epilepsy awarenessAn eighth-grader named Andy Barrett utilized a school 3D printer to design and sell custom fidget toys. He successfully created and sold ap...
- Long-term investing: One reason is good enough, and a must, to own a business. 8 stocks with an upside potential of up to 36%In today’s world, investors cannot assume that correlations that worked in the past will work in exactly the same manner now. We are in a p...
- For investors with ability to ignore short-term volatility: 5 mid-cap stocks from different sectors with upside potential up to 19%Most of what impacts the market these days comes from outside the country: Oil price spikes, tariff threats, FII pull out. There is, howeve...
- From gut bacteria to the brain, a chemical, sodium butyrate traveled through the bloodstream after traumatic injury, where 4 months of treatment helped scientists reduce inflammation, protect brain cells and made seizures less frequentPost-traumatic epilepsy treatment: Researchers are exploring sodium butyrate to prevent post-traumatic epilepsy after brain injuries. This ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsLooking at what happens in the short term is important, as it does have an impact on stock prices. But also always keep an eye on the macro...
- Mid-cap stocks: Time for a change of stance? 6 mid-caps from different sectors with an upside potential up to 29%Sometimes the real market story is not in the headline index. The Nifty and Sensex can be under pressure, and yet, below them, mid- and sma...
- In 2017, two parents asked scientist Stanley Crooke to create treatments for their children's rare mutations. Years later, a custom drug cut one boy's seizures by 90% and helped him walk on his own for the first timeMedicine is undergoing a profound transformation by shifting focus from populations to individual patients. A novel custom drug for rare ge...
- For those with an investment horizon of over 1 year: 5 mid-cap stocks from different sectors with upside potential up to 30%For a while now, the world's risk appetite has been pouring into one story above all others: The AI trade, and into markets most tied to it...
- For investors with 1- to 2-year perspective and ability to ignore volatility: 6 stocks with an upside potential of up to 26%The US-Iran war is escalating again, with all that means for crude prices and nervous markets. And halfway across the world, the long AI tr...
- AI tool helps researchers treat child epilepsyAustralian researchers have developed an AI tool that helps spot tiny brain malformations in children with epilepsy, often missed in scans....
- A high-fat low-carb diet coupled with the right meds can curb seizures: StudyThe right lifestyle can prevent fits to a large extent.
- Silent, subtle & unseen: Why are seizures hard to diagnose? Identifying and improving gaps in epilepsy careA seizure is caused by sudden uncontrolled electrical activity from a group of neurons.
- Contribution of neuro NCDs to India's disease burden more than doubled from 1990-2009According to the findings, the burden of non-communicable neurological disorders is increasing in India mainly due to the ageing of the pop...
- Made-in-India drugs to be based on weed soonThe move to produce medicine formulations that incorporate hemp lend a fresh reputation to the otherwise controversial cannabis
- Good news for epileptic patients: Implanting new device in brain can prevent seizuresThe researchers used a neurotransmitter which acts as the 'brake' at the source.
- SPARC and Sun Pharma ink licensing pact for epilepsy drug"As per the agreement, SPARC will license Elepsia XRTM (Levetiracetam Extended Release tablets) to a wholly-owned subsidiary of Sun Pharma ...
- SPARC shares settle with 5 per cent gain; market capitalisation up by Rs 440 croreELEPSIA XR is indicated for adjunctive therapy in the treatment of partial onset seizures in patients of 12 years of age and older with epi...
- SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."
- Delhi High Court comes to Intas rescue, stops Arinna Lifescience for trademark violationDelhi High Court gave relief to Ahmedabad-based drug maker, Intas Pharmaceuticals, by granting an ex-parte injunction against the sale of V...
Load More
